Acorda Therapeutics, Inc. Debt to Equity Ratio 2010-2024 | ACORQ
Current and historical debt to equity ratio values for Acorda Therapeutics, Inc. (ACORQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Acorda Therapeutics, Inc. debt/equity for the three months ending March 31, 2024 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-03-31 |
$0.27B |
$-0.19B |
-1.44 |
2023-12-31 |
$0.27B |
$-0.16B |
-1.69 |
2023-09-30 |
$0.31B |
$0.06B |
5.21 |
2023-06-30 |
$0.30B |
$0.07B |
4.37 |
2023-03-31 |
$0.30B |
$0.08B |
3.87 |
2022-12-31 |
$0.30B |
$0.09B |
3.23 |
2022-09-30 |
$0.32B |
$0.08B |
4.19 |
2022-06-30 |
$0.32B |
$0.09B |
3.62 |
2022-03-31 |
$0.30B |
$0.13B |
2.33 |
2021-12-31 |
$0.30B |
$0.15B |
2.01 |
2021-09-30 |
$0.30B |
$0.16B |
1.83 |
2021-06-30 |
$0.30B |
$0.19B |
1.58 |
2021-03-31 |
$0.38B |
$0.21B |
1.83 |
2020-12-31 |
$0.40B |
$0.24B |
1.66 |
2020-09-30 |
$0.40B |
$0.31B |
1.27 |
2020-06-30 |
$0.44B |
$0.29B |
1.50 |
2020-03-31 |
$0.45B |
$0.31B |
1.46 |
2019-12-31 |
$0.49B |
$0.31B |
1.57 |
2019-09-30 |
$0.60B |
$0.28B |
2.13 |
2019-06-30 |
$0.65B |
$0.55B |
1.20 |
2019-03-31 |
$0.67B |
$0.57B |
1.18 |
2018-12-31 |
$0.69B |
$0.61B |
1.12 |
2018-09-30 |
$0.71B |
$0.60B |
1.19 |
2018-06-30 |
$0.64B |
$0.61B |
1.06 |
2018-03-31 |
$0.64B |
$0.55B |
1.16 |
2017-12-31 |
$0.68B |
$0.52B |
1.30 |
2017-09-30 |
$0.67B |
$0.68B |
0.98 |
2017-06-30 |
$0.64B |
$0.69B |
0.93 |
2017-03-31 |
$0.64B |
$0.68B |
0.95 |
2016-12-31 |
$0.68B |
$0.66B |
1.02 |
2016-09-30 |
$0.65B |
$0.67B |
0.98 |
2016-06-30 |
$0.67B |
$0.68B |
0.98 |
2016-03-31 |
$0.53B |
$0.68B |
0.77 |
2015-12-31 |
$0.51B |
$0.60B |
0.84 |
2015-09-30 |
$0.53B |
$0.58B |
0.91 |
2015-06-30 |
$0.54B |
$0.56B |
0.96 |
2015-03-31 |
$0.55B |
$0.55B |
1.00 |
2014-12-31 |
$0.53B |
$0.54B |
0.97 |
2014-09-30 |
$0.45B |
$0.52B |
0.86 |
2014-06-30 |
$0.44B |
$0.50B |
0.89 |
2014-03-31 |
$0.16B |
$0.45B |
0.36 |
2013-12-31 |
$0.17B |
$0.44B |
0.38 |
2013-09-30 |
$0.16B |
$0.43B |
0.38 |
2013-06-30 |
$0.17B |
$0.41B |
0.42 |
2013-03-31 |
$0.17B |
$0.39B |
0.44 |
2012-12-31 |
$0.18B |
$0.39B |
0.47 |
2012-09-30 |
$0.17B |
$0.25B |
0.67 |
2012-06-30 |
$0.17B |
$0.23B |
0.76 |
2012-03-31 |
$0.17B |
$0.22B |
0.76 |
2011-12-31 |
$0.17B |
$0.21B |
0.85 |
2011-09-30 |
$0.16B |
$0.19B |
0.88 |
2011-06-30 |
$0.17B |
$0.16B |
1.07 |
2011-03-31 |
$0.18B |
$0.16B |
1.17 |
2010-12-31 |
$0.19B |
$0.15B |
1.26 |
2010-09-30 |
$0.19B |
$0.14B |
1.33 |
2010-06-30 |
$0.17B |
$0.12B |
1.41 |
2010-03-31 |
$0.20B |
$0.12B |
1.58 |
2009-12-31 |
$0.18B |
$0.14B |
1.33 |
2009-09-30 |
$0.18B |
$0.16B |
1.16 |
2009-06-30 |
$0.20B |
$0.17B |
1.14 |
2009-03-31 |
$0.07B |
$0.19B |
0.37 |